CPT1C and cancer: Additionally, a study using The Cancer Genome Atlas (TCGA) dataset showed that CPT1C is part of the 5-gene metabolic signature associated with epithelial-mesenchymal transition, metastatic progression, and poor prognosis across multiple cancers [25].